Exact Mass: 313.0674986

Exact Mass Matches: 313.0674986

Found 287 metabolites which its exact mass value is equals to given mass value 313.0674986, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Hexaconazole

Pesticide6_Hexaconazole_C14H17Cl2N3O_2-(2,4-Dichlorophenyl)-1-(1H-1,2,4-triazol-1-yl)-2-hexanol

C14H17Cl2N3O (313.07486120000004)

CONFIDENCE standard compound; INTERNAL_ID 1269; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9950; ORIGINAL_PRECURSOR_SCAN_NO 9948 CONFIDENCE standard compound; INTERNAL_ID 1269; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9938; ORIGINAL_PRECURSOR_SCAN_NO 9937 CONFIDENCE standard compound; INTERNAL_ID 1269; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9900; ORIGINAL_PRECURSOR_SCAN_NO 9899 CONFIDENCE standard compound; INTERNAL_ID 1269; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9947; ORIGINAL_PRECURSOR_SCAN_NO 9942 CONFIDENCE standard compound; INTERNAL_ID 1269; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9912; ORIGINAL_PRECURSOR_SCAN_NO 9911 CONFIDENCE standard compound; INTERNAL_ID 1269; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9988; ORIGINAL_PRECURSOR_SCAN_NO 9986

Triazophos

Diethoxy-[(1-phenyl-1,2,4-triazol-3-yl)oxy]-sulphanylidene-$l^{5}-phosphane

C12H16N3O3PS (313.06499560000003)

CONFIDENCE standard compound; INTERNAL_ID 1193; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9355; ORIGINAL_PRECURSOR_SCAN_NO 9354 CONFIDENCE standard compound; INTERNAL_ID 1193; DATASET 20200303_ENTACT_RP_MIX503; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9217; ORIGINAL_PRECURSOR_SCAN_NO 9214 CONFIDENCE standard compound; INTERNAL_ID 1193; DATASET 20200303_ENTACT_RP_MIX503; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9286; ORIGINAL_PRECURSOR_SCAN_NO 9281 CONFIDENCE standard compound; INTERNAL_ID 1193; DATASET 20200303_ENTACT_RP_MIX503; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9227; ORIGINAL_PRECURSOR_SCAN_NO 9226 CONFIDENCE standard compound; INTERNAL_ID 1193; DATASET 20200303_ENTACT_RP_MIX503; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9231; ORIGINAL_PRECURSOR_SCAN_NO 9228 CONFIDENCE standard compound; INTERNAL_ID 1193; DATASET 20200303_ENTACT_RP_MIX503; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9272; ORIGINAL_PRECURSOR_SCAN_NO 9270 C471 - Enzyme Inhibitor > C47792 - Acetylcholinesterase Inhibitor

Isazofos

O-5-chloro-1-(propan-2-yl)-1H-1,2,4-triazol-3-yl O,O-diethyl phosphorothioate

C9H17ClN3O3PS (313.04167320000005)

CONFIDENCE standard compound; INTERNAL_ID 1018; DATASET 20200303_ENTACT_RP_MIX502; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9196; ORIGINAL_PRECURSOR_SCAN_NO 9194 CONFIDENCE standard compound; INTERNAL_ID 1018; DATASET 20200303_ENTACT_RP_MIX502; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9177; ORIGINAL_PRECURSOR_SCAN_NO 9175 CONFIDENCE standard compound; INTERNAL_ID 1018; DATASET 20200303_ENTACT_RP_MIX502; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9178; ORIGINAL_PRECURSOR_SCAN_NO 9174 CONFIDENCE standard compound; INTERNAL_ID 1018; DATASET 20200303_ENTACT_RP_MIX502; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9185; ORIGINAL_PRECURSOR_SCAN_NO 9183 CONFIDENCE standard compound; INTERNAL_ID 1018; DATASET 20200303_ENTACT_RP_MIX502; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9194; ORIGINAL_PRECURSOR_SCAN_NO 9190 CONFIDENCE standard compound; INTERNAL_ID 1018; DATASET 20200303_ENTACT_RP_MIX502; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9212; ORIGINAL_PRECURSOR_SCAN_NO 9210 C471 - Enzyme Inhibitor > C47792 - Acetylcholinesterase Inhibitor

Cyclic dAMP

3,5-Cyclic dAMP

C10H12N5O5P (313.0576032)

5'-Phosphoribosyl-N-formylglycinamidine

[(2R,3S,4R,5R)-5-[(Z)-(1-amino-2-formamidoethylidene)amino]-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate

C8H16N3O8P (313.0674986)

5-Phosphoribosyl-N-formylglycinamidine, also known as FGAM or phosphoribosylformylglycinamidine, belongs to the class of organic compounds known as pentose phosphates. These are carbohydrate derivatives containing a pentose substituted by one or more phosphate groups. FGAM is a very strong basic compound (based on its pKa). Within humans, FGAM participates in several enzymatic reactions. FGAM is an intermediate in purine metabolism and it can be biosynthesized (along with L-glutamic acid) from 5-phosphoribosyl-N-formylglycinamide (FGAR) and L-glutamine. This reaction is catalyzed by the enzyme phosphoribosylformylglycinamidine synthase (EC 6.3.5.3). Additionally, FGAM can be converted into aminoimidazole ribotide (AIR) through its interaction with the enzyme trifunctional purine biosynthetic protein adenosine-3 (EC 6.3.3.1). Outside of the human body, FGAM has been detected, but not quantified in, several different foods, such as Welsh onions, green beans, chicories, European cranberries, and Mexican oregano. This could make FGAM a potential biomarker for the consumption of these foods. 5-Phosphoribosyl-n-formylglycineamidine is a substrate for Glucosamine-6-phosphate isomerase. [HMDB]. Phosphoribosylformylglycineamidine is found in many foods, some of which are greenthread tea, cardamom, mulberry, and carrot. COVID info from COVID-19 Disease Map Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

Melicopine

1,3-Dioxolo[4,5-c]acridin-6(11H)-one,4,5-dimethoxy-11-methyl-

C17H15NO5 (313.095018)

Karphos

ISOXATHION

C13H16NO4PS (313.0537626)

CONFIDENCE standard compound; INTERNAL_ID 790; DATASET 20200303_ENTACT_RP_MIX501; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9696; ORIGINAL_PRECURSOR_SCAN_NO 9695 CONFIDENCE standard compound; INTERNAL_ID 790; DATASET 20200303_ENTACT_RP_MIX501; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9735; ORIGINAL_PRECURSOR_SCAN_NO 9730 CONFIDENCE standard compound; INTERNAL_ID 790; DATASET 20200303_ENTACT_RP_MIX501; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9644; ORIGINAL_PRECURSOR_SCAN_NO 9642 CONFIDENCE standard compound; INTERNAL_ID 790; DATASET 20200303_ENTACT_RP_MIX501; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9682; ORIGINAL_PRECURSOR_SCAN_NO 9680 CONFIDENCE standard compound; INTERNAL_ID 790; DATASET 20200303_ENTACT_RP_MIX501; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9725; ORIGINAL_PRECURSOR_SCAN_NO 9724 CONFIDENCE standard compound; INTERNAL_ID 790; DATASET 20200303_ENTACT_RP_MIX501; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9709; ORIGINAL_PRECURSOR_SCAN_NO 9708

Chlorozotocin

D-Glucose, 2-((((2-chloroethyl)nitrosoamino)carbonyl)amino)-2-deoxy-

C9H16ClN3O7 (313.06767360000003)

C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent D009676 - Noxae > D002273 - Carcinogens D000970 - Antineoplastic Agents

Amoxapine

13-chloro-10-(piperazin-1-yl)-2-oxa-9-azatricyclo[9.4.0.0³,⁸]pentadeca-1(11),3,5,7,9,12,14-heptaene

C17H16ClN3O (313.09818359999997)

Amoxapine, the N-demethylated derivative of the antipsychotic agent loxapine, is a dibenzoxazepine-derivative tricyclic antidepressant (TCA). TCAs are structurally similar to phenothiazines. They contain a tricyclic ring system with an alkyl amine substituent on the central ring. In non-depressed individuals, amoxapine does not affect mood or arousal, but may cause sedation. In depressed individuals, amoxapine exerts a positive effect on mood. TCAs are potent inhibitors of serotonin and norepinephrine reuptake. In addition, TCAs down-regulate cerebral cortical β-adrenergic receptors and sensitize post-synaptic serotonergic receptors with chronic use. The antidepressant effects of TCAs are thought to be due to an overall increase in serotonergic neurotransmission. TCAs also block histamine H₁ receptors, α₁-adrenergic receptors and muscarinic receptors, which accounts for their sedative, hypotensive and anticholinergic effects (e.g. blurred vision, dry mouth, constipation, urinary retention), respectively. See toxicity section below for a complete listing of side effects. Amoxapine may be used to treat neurotic and reactive depressive disorders, endogenous and psychotic depression, and mixed symptoms of depression and anxiety or agitation. N - Nervous system > N06 - Psychoanaleptics > N06A - Antidepressants > N06AA - Non-selective monoamine reuptake inhibitors D018377 - Neurotransmitter Agents > D014179 - Neurotransmitter Uptake Inhibitors > D018759 - Adrenergic Uptake Inhibitors D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017367 - Selective Serotonin Reuptake Inhibitors C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent > C94727 - Tricyclic Antidepressant D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents D049990 - Membrane Transport Modulators

Flunitrazepam

5-(O-Fluorophenyl)-1,3-dihydro-1-methyl-7-nitro-2H-1,4-benzodiazepin-2-one

C16H12FN3O3 (313.0862654)

A benzodiazepine with pharmacologic actions similar to those of diazepam that can cause anterograde amnesia. Some reports indicate that it is used as a date rape drug and suggest that it may precipitate violent behavior. The United States Government has banned the importation of this drug. [PubChem] N - Nervous system > N05 - Psycholeptics > N05C - Hypnotics and sedatives > N05CD - Benzodiazepine derivatives D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants D018377 - Neurotransmitter Agents > D018682 - GABA Agents > D018757 - GABA Modulators C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent

Phosphoribosylformylglycinamidine

{[(2R,3S,4R,5R)-5-[N-(carbamimidoylmethyl)formamido]-3,4-dihydroxyoxolan-2-yl]methoxy}phosphonic acid

C8H16N3O8P (313.0674986)

Phosphoribosylformylglycinamidine, also known as formylglycinamidine ribonucleotide (FGAM), is a substrate for glucosamine-6-phosphate isomerase. Phosphoribosylformylglycinamidine is found in many foods, some of which are greenthread tea, cardamom, mulberry, and carrot. 5-Phosphoribosyl-n-formylglycineamidine is a substrate for Glucosamine-6-phosphate isomerase. [HMDB]. Phosphoribosylformylglycineamidine is found in many foods, some of which are greenthread tea, cardamom, mulberry, and carrot. COVID info from COVID-19 Disease Map Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

(S)-5'-Deoxy-5'-(methylsulfinyl)adenosine

2-(6-Amino-9H-purin-9-yl)-5-(methanesulphinylmethyl)oxolane-3,4-diol

C11H15N5O4S (313.08447100000006)

(S)-5-Deoxy-5-(methylsulfinyl)adenosine is found in mushrooms. (S)-5-Deoxy-5-(methylsulfinyl)adenosine is produced by Ganoderma lucidum (reishi). Production by Ganoderma lucidum (reishi). (R)-5-Deoxy-5-(methylsulfinyl)adenosine is found in mushrooms.

Avenanthramide 1f

2-{[(2E)-1-hydroxy-3-(4-hydroxy-3-methoxyphenyl)prop-2-en-1-ylidene]amino}benzoate

C17H15NO5 (313.095018)

Avenanthramide 1f is a polyphenol compound found in foods of plant origin (PMID: 20428313)

Tyramine glucuronide

(2S,3S,4S,5R,6S)-6-[4-(2-aminoethyl)phenoxy]-3,4,5-trihydroxyoxane-2-carboxylic acid

C14H19NO7 (313.1161464)

Tyramine glucuronide is a natural human metabolite of Tyramine generated in the liver by UDP glucuonyltransferase. Glucuronidation is used to assist in the excretion of toxic substances, drugs or other substances that cannot be used as an energy source. Glucuronic acid is attached via a glycosidic bond to the substance, and the resulting glucuronide, which has a much higher water solubility than the original substance, is eventually excreted by the kidneys. Tyramine glucuronide is a natural human metabolite of Tyramine generated in the liver by UDP glucuonyltransferase.

Avenanthramide E

2-{[(2Z)-1-hydroxy-3-(4-hydroxy-3-methoxyphenyl)prop-2-en-1-ylidene]amino}benzoate

C17H15NO5 (313.095018)

(Z)-Avenanthramide E is found in cereals and cereal products. (Z)-Avenanthramide E is isolated from oat. Isolated from the oat Avena sativa. Avenanthramide E is found in oat and cereals and cereal products.

2-Methylthioadenosine

2-[6-amino-2-(methylsulfanyl)-9H-purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol

C11H15N5O4S (313.08447100000006)

4-(4-Guanidinobenzoyloxy)phenylacetate

2-(4-{4-[(diaminomethylidene)amino]benzoyloxy}phenyl)acetic acid

C16H15N3O4 (313.106251)

4-Hydroxy Duloxetine

4-[3-(methylamino)-1-(thiophen-2-yl)propoxy]naphthalen-1-ol

C18H19NO2S (313.1136434)

L-Chlorozotocin

1-(2-chloroethyl)-1-nitroso-3-(3,4,5,6-tetrahydroxy-1-oxohexan-2-yl)urea

C9H16ClN3O7 (313.06767360000003)

D009676 - Noxae > D002273 - Carcinogens D000970 - Antineoplastic Agents

BEMESETRON

8-methyl-8-azabicyclo[3.2.1]octan-3-yl 3,5-dichlorobenzoate

C15H17Cl2NO2 (313.06362820000004)

Benorilate

N-{4-[2-(acetyloxy)benzoyloxy]phenyl}ethanimidate

C17H15NO5 (313.095018)

N - Nervous system > N02 - Analgesics > N02B - Other analgesics and antipyretics > N02BA - Salicylic acid and derivatives D000893 - Anti-Inflammatory Agents > D000894 - Anti-Inflammatory Agents, Non-Steroidal > D012459 - Salicylates C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D018501 - Antirheumatic Agents

Flubendazole

N-[6-(4-fluorobenzoyl)-1H-1,3-benzodiazol-2-yl]methoxycarboximidic acid

C16H12FN3O3 (313.0862654)

P - Antiparasitic products, insecticides and repellents > P02 - Anthelmintics > P02C - Antinematodal agents > P02CA - Benzimidazole derivatives D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000871 - Anthelmintics C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C250 - Antihelminthic Agent Flubendazole is an anthelmintic drug based on altering microtubule structure, inhibition of tubulin polymerization and disruption of microtubule function. Flubendazole induces apoptosis in human colorectal cancer (CRC) by blocking the STAT3 signaling axis and activation of autophagy. Flubendazole induces P53 expression and reduced Cyclin B1 and p-cdc2 expression. Flubendazole is an antitumor agent. Flubendazole can be used for worm and intestinal parasites[1][2].

Mitonafide

3-[2-(dimethylamino)ethyl]-11-nitro-3-azatricyclo[7.3.1.0^{5,13}]trideca-1(13),5,7,9,11-pentaene-2,4-dione

C16H15N3O4 (313.106251)

C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D007364 - Intercalating Agents D000890 - Anti-Infective Agents > D000998 - Antiviral Agents D000970 - Antineoplastic Agents

N-(4-Methylphenyl)diphenimide

9-(4-methylphenyl)-9-azatricyclo[9.4.0.0^{2,7}]pentadeca-1(15),2,4,6,11,13-hexaene-8,10-dione

C21H15NO2 (313.110273)

Pipethiadene

4-{6,8-dithiatricyclo[8.4.0.0^{3,7}]tetradeca-1(14),3(7),4,10,12-pentaen-2-ylidene}-1-methylpiperidine

C18H19NS2 (313.0958854)

Rentiapril

2-(2-Hydroxyphenyl)-3-(3-sulphanylpropanoyl)-1,3-thiazolidine-4-carboxylic acid

C13H15NO4S2 (313.044247)

Salicylamide glucuronide

3,4,5-Trihydroxy-6-[2-(C-hydroxycarbonimidoyl)phenoxy]oxane-2-carboxylate

C13H15NO8 (313.079763)

N-(5-Chlorosalicyloyl)-8-aminocaprylic acid

8-{[(5-chloro-2-hydroxyphenyl)(hydroxy)methylidene]amino}octanoate

C14H19NO7_(2R)-2-(beta-D-Glucopyranosyloxy)-2-phenylacetamide

NCGC00385280-01_C14H19NO7_(2R)-2-(beta-D-Glucopyranosyloxy)-2-phenylacetamide

C14H19NO7 (313.1161464)

3,5-Cyclic dAMP

C10H12N5O5P (313.0576032)

3,5-Cyclic 2-Deoxyadenosine monophosphate

C10H12N5O5P (313.0576032)

2-Deoxyadenosine cyclic 3,5-(hydrogen phosphate)

C10H12N5O5P (313.0576032)

MMV688776

C17H16N3OCl (313.0981836)

(6R)-5,6,7,8-Tetrahydro-L-biopterin dihydrochloride

C9H17Cl2N5O3 (313.0708392)

Benorylate

C17H15NO5 (313.095018)

amoxapine

C17H16ClN3O (313.09818359999997)

N - Nervous system > N06 - Psychoanaleptics > N06A - Antidepressants > N06AA - Non-selective monoamine reuptake inhibitors D018377 - Neurotransmitter Agents > D014179 - Neurotransmitter Uptake Inhibitors > D018759 - Adrenergic Uptake Inhibitors D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017367 - Selective Serotonin Reuptake Inhibitors C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent > C94727 - Tricyclic Antidepressant D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents D049990 - Membrane Transport Modulators CONFIDENCE standard compound; INTERNAL_ID 902; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7940; ORIGINAL_PRECURSOR_SCAN_NO 7938 CONFIDENCE standard compound; INTERNAL_ID 902; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7961; ORIGINAL_PRECURSOR_SCAN_NO 7960 CONFIDENCE standard compound; INTERNAL_ID 902; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7991; ORIGINAL_PRECURSOR_SCAN_NO 7989 CONFIDENCE standard compound; INTERNAL_ID 902; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7990; ORIGINAL_PRECURSOR_SCAN_NO 7988 CONFIDENCE standard compound; INTERNAL_ID 902; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7970; ORIGINAL_PRECURSOR_SCAN_NO 7967 CONFIDENCE standard compound; INTERNAL_ID 902; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7997; ORIGINAL_PRECURSOR_SCAN_NO 7994

Salinosporamide A

C15H20ClNO4 (313.10807900000003)

A salinosporamide in which the core (1R)-6-oxa-2-azabicyclo[3.2.0]heptane-3,7-dione skeleton is substituted at positions 1, 4, and 5 by (1S)-cyclohex-2-en-1-yl(hydroxy)methyl, 2-chloroethyl, and methyl groups, respectively (the 1R,4R,5S diastereoisomer). A potent proteasome inhibitor, it has attracted interest for potential use in the treatment of various cancers.

2-Methylthioadenosine; LC-tDDA; CE10

C11H15N5O4S (313.08447100000006)

2-Methylthioadenosine; LC-tDDA; CE20

C11H15N5O4S (313.08447100000006)

2-Methylthioadenosine; LC-tDDA; CE30

C11H15N5O4S (313.08447100000006)

2-Methylthioadenosine; LC-tDDA; CE40

C11H15N5O4S (313.08447100000006)

2-Methylthioadenosine; AIF; 0eV; CorrDec

C11H15N5O4S (313.08447100000006)

2-Methylthioadenosine; AIF; 30eV; CorrDec

C11H15N5O4S (313.08447100000006)

2-Methylthioadenosine; AIF; 10eV; CorrDec

C11H15N5O4S (313.08447100000006)

2-Methylthioadenosine; AIF; 0eV; MS2Dec

C11H15N5O4S (313.08447100000006)

2-Methylthioadenosine; AIF; 10eV; MS2Dec

C11H15N5O4S (313.08447100000006)

2-Methylthioadenosine; AIF; 30eV; MS2Dec

C11H15N5O4S (313.08447100000006)

Benorilate

C17H15NO5 (313.095018)

PI3-Kinase &alpha

3-[4-(4-morpholinyl)thieno[3,2-d]pyrimidin-2-yl-phenol

C16H15N3O2S (313.088493)

Tyramine glucuronide

4-(2-Aminoethyl)phenyl-beta-delta-glucopyranosiduronic acid

C14H19NO7 (313.1161464)

PMAC

10-methyl-9-(phenoxycarbonyl) Acridinium fluorosulfonate

C21H15NO2 (313.110273)

albendazole (II)

C12H15N3O5S (313.073238)

Avenanthramide 1f

2-[(2E)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enamido]benzoic acid

C17H15NO5 (313.095018)

5'-Deoxy-5'-(methylsulfinyl)adenosine, 9CI

2-(6-amino-9H-purin-9-yl)-5-(methanesulfinylmethyl)oxolane-3,4-diol

C11H15N5O4S (313.08447100000006)

Avenanthramide E

2-[(2Z)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enamido]benzoic acid

C17H15NO5 (313.095018)

D-Glucose,2-deoxy-2-[[(phenylmethoxy)carbonyl]amino]-

C14H19NO7 (313.1161464)

9-Benzyl-9H-carbazole-3,6-dicarbaldehyde

C21H15NO2 (313.110273)

(1R,2S)-Methyl 1-amino-2-vinylcyclopropanecarboxylate 4-methylbenzenesulfonate

C14H19NO5S (313.09838840000003)

6-(BROMOMETHYL)-4-(3-METHOXYPROPYL)-2H-BENZO[B][1,4]OXAZIN-3(4H)-ONE

C13H16BrNO3 (313.0313486)

tert-Butyl 7,8-dihydro-2-(methylsulfonyl)pyrido[4,3-d]pyrimidine-6(5H)-carboxylate

C13H19N3O4S (313.10962140000004)

[2-(4,6-DIMETHYL-QUINAZOLIN-2-YLAMINO)-5-OXO-4,5-DIHYDRO-1H-IMIDAZOL-4-YL]-ACETIC ACID

C15H15N5O3 (313.117484)

Sulfadoxine D3

C12H11D3N4O4S (313.092403934)

2-(1-Oxy-pyridin-2-yl)-1,1,3,3-tetramethylisothiouronium tetrafluoroborate

C10H16BF4N3OS (313.1043204)

5-(4-BROMO-PHENYL)-2-PHENYL-2H-PYRAZOL-3-YLAMINE

C15H12BrN3 (313.0214532)

HDAOS

C11H16NNaO6S (313.0595996)

4-Nitrobenzo-15-crown-5

C14H19NO7 (313.1161464)

1-Diphenylmethylindoline-2,3-dione

C21H15NO2 (313.110273)

1,4-Dihydro-1-(6-methoxy-1H-benzimidazol-2-yl)-3,5-dimethyl-4-oxo-2-pyridinecarboxylic acid

C16H15N3O4 (313.106251)

Boc-D-N-Me-Phe-OH

C15H20ClNO4 (313.10807900000003)

9,10-Anthracenedione,1-amino-4-hydroxy-2-(2-methoxyethoxy)-

C17H15NO5 (313.095018)

Boc-(R)-3-AMino-4-(3-chloro-phenyl)-butyric acid

C15H20ClNO4 (313.10807900000003)

5-(3-bromophenyl)-2-phenylpyrazol-3-amine

C15H12BrN3 (313.0214532)

2-BROMO-4-METHOXY-6-NITROBENZENOL

C13H16BrNO3 (313.0313486)

Fmoc-aoac-oh

C17H15NO5 (313.095018)

[2-(3-BROMO-PHENYL)-2-OXO-ETHYL]-CARBAMIC ACID TERT-BUTYL ESTER

C13H16BrNO3 (313.0313486)

3,5-DI(BENZO(D)OXAZOL-2-YL)PYRIDINE

C19H11N3O2 (313.0851226)

4-BROMO-N,N-DIISOPROPYL-3-METHOXYBENZAMIDE

C14H20BrNO2 (313.06773200000003)

BenzeneMethanol, α-(aminomethyl)-α-(4-chlorophenyl)-4-(1H-pyrazol-4-yl)-

C17H16ClN3O (313.09818359999997)

7-piperazin-1-yl-2-(3-pyridyl)thiazolo[5,4-d]pyrimidin-5-amine

C14H15N7S (313.11095900000004)

(2S, 3S)-3-(Boc-amino)-2-Methyl-3-(4-chlorophenyl)propionic acid

C15H20ClNO4 (313.10807900000003)

ethyl 5-oxo-3-[3-(trifluoromethyl)phenyl]-2H-1,2,4-triazine-6-carboxylate

C13H10F3N3O3 (313.0674226)

Naphthol AS-BO

C21H15NO2 (313.110273)

MDL 72222

C15H17Cl2NO2 (313.06362820000004)

Bemesetron (MDL 72222) is a selective 5-HT3 receptor antagonist with an IC50 of 0.33 nM[1]. Neuroprotective effect[2].

piclonidine

C14H17Cl2N3O (313.07486120000004)

tert-Butyl 6-bromo-2H-benzo[b][1,4]oxazine-4(3H)-carboxylate

C13H16BrNO3 (313.0313486)

5-[(4-METHOXYPHENOXY)METHYL]-4-PHENYL-4H-1,2,4-TRIAZOLE-3-THIOL

C16H15N3O2S (313.088493)

2-(7-amino-4-methyl-2-oxo-6-sulfochromen-3-yl)acetic acid

C12H11NO7S (313.0256216)

N-Acetyl-3,5-dinitrotyrosine

C11H11N3O8 (313.0546126)

3-Hydroxy-N-2-naphthyl-2-naphthamide

C21H15NO2 (313.110273)

3-(2,6-dichloro-phenyl)-5-isopropyl-isoxazole-4-carboxylic acid methyl ester

C14H13Cl2NO3 (313.02724480000006)

YM 976

4-(3-Chlorophenyl)-1,7-diethylpyrido[2,3-d]pyrimidin-2(1H)-one

C17H16ClN3O (313.09818359999997)

Rentiapril

C13H15NO4S2 (313.044247)

Sapropterin dihydrochloride

(6R)-5,6,7,8-Tetrahydro-L-biopterin dihydrochloride

C9H17Cl2N5O3 (313.0708392)

C26170 - Protective Agent > C275 - Antioxidant

3-(2,6-Dimethylmorpholin-4-yl)-4-methylsulfonylbenzoicacid

C14H19NO5S (313.09838840000003)

tert-Butyl N-[2-(4-bromophenyl)-2-oxoethyl]carbamate

C13H16BrNO3 (313.0313486)

(4R,5S)-5-(3,5-bis(trifluoroMethyl)phenyl)-4-Methyloxazolidin-2-one

C12H9F6NO2 (313.0537446)

Boc-(R)-3-amino-4-(4-chlorophenyl)-butyric acid

C15H20ClNO4 (313.10807900000003)

4-[(4-Bromo-2-ethoxyphenyl)carbonyl]morpholine

C13H16BrNO3 (313.0313486)

Ethyl 4-(methylsulfonyl)-2-(4-morpholinyl)benzoate

C14H19NO5S (313.09838840000003)

TERT-BUTYL (5-BROMOPYRIMIDIN-2-YL)(CYCLOPROPYL)CARBAMATE

C12H16BrN3O2 (313.0425816)

4-(4-Methoxyphenoxy)-3-nitrobenzotrifluoride

C14H10F3NO4 (313.0561896)

3-[[1-(2,4-DICHLOROPHENYL)-2-(1H-IMIDAZOL-1-YL)ETHYL]AMINO]-1-PROPANOL

C14H17Cl2N3O (313.07486120000004)

DIETHYL 2-(4-CHLOROBENZAMIDO)MALONATE

C14H16ClNO5 (313.0716956)

2-(3-BROMO-PHENYL)-5-PHENYL-2H-PYRAZOL-3-YLAMINE

C15H12BrN3 (313.0214532)

2-(4-BROMO-PHENYL)-5-PHENYL-2H-PYRAZOL-3-YLAMINE

C15H12BrN3 (313.0214532)

3-(CHLOROPHENYLMETHYL)-1H-INDOLE-2-CARBOXYLIC ACID ETHYL ESTER

C18H16ClNO2 (313.0869506)

Boc-(S)-3-amino-4-(2-chlorophenyl)-butyric acid

C15H20ClNO4 (313.10807900000003)

Boc-(S)-3-Amino-4-(3-chloro-phenyl)-butyric acid

C15H20ClNO4 (313.10807900000003)

Boc-(S)-3-Amino-4-(4-chloro-phenyl)-butyric acid

C15H20ClNO4 (313.10807900000003)

(4R,5S)-5-[3,5-bis(trifluoromethyl)phenyl]-4-methyl-1,3-oxazolidin-2-one

C12H9F6NO2 (313.0537446)

N-butylsulfonate Pyridinium hydrogensulfate

C9H15NO7S2 (313.028992)

(2-Methyl-4-phenylquinolin-3-yl)acetic acid hydrochloride

C18H16ClNO2 (313.0869506)

1-boc-amino-2-bromo-4-carbamimidoyl-benzene

C12H16BrN3O2 (313.0425816)

3-THIOPHENECARBOXYLIC ACID, 2-[(2-CHLOROACETYL)AMINO]-4-(2-FURANYL)-, ETHYL ESTER

C13H12ClNO4S (313.0175542)

5-BroMo-2-Methoxypyridine-3-boronic acid, pinacol ester

C12H17BBrNO3 (313.0484782000001)

alpha-d-mannopyranosylphenyl isothiocyanate

C13H15NO6S (313.062005)

2-[[(4-AMINOPHENYL)SULFONYL]AMINO]-4-THIAZOLEACETIC ACID

C11H11N3O4S2 (313.0190966)

(3-(N-cyclohexylsulfamoyl)-4-Methoxyphenyl)boronic acid

C13H20BNO5S (313.11551800000007)

2-N-BOC-2-AMINOMETHYL-3-(3-CHLORO-PHENYL)-PROPIONIC ACID

C15H20ClNO4 (313.10807900000003)

1-Naphthalenesulfonicacid, 8-[(4-methylphenyl)amino]-

C17H15NO3S (313.07726)

8-chloro-1-methyl-6-(2,3,4,5,6-pentadeuteriophenyl)-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine

C17H8ClD5N4 (313.11425469)

Carboxypeptidase G2 (CPG2) Inhibitor

C13H15NO6S (313.062005)

2-(Fluoroacetyl)-3-(2-methylphenyl)-6-nitroquinazolin-4(3H)-one

C16H12FN3O3 (313.0862654)

5-CHLORO-2-(3-HYDROXYMETHYL-4H-1,2,4-TRIAZOL-4-YL)BENZOPHENONE

C16H12ClN3O2 (313.0618002)

Amezinium metilsulfate

Amezinium methylsulfate

C12H15N3O5S (313.073238)

C - Cardiovascular system > C01 - Cardiac therapy > C01C - Cardiac stimulants excl. cardiac glycosides > C01CA - Adrenergic and dopaminergic agents D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013566 - Sympathomimetics C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist D004791 - Enzyme Inhibitors > D008996 - Monoamine Oxidase Inhibitors Amezinium metilsulfate has multiple mechanisms, including stimulation of alpha and beta-1 receptors and inhibition ofnoradrenaline and tyramine uptake. Target: alpha and beta-1 receptors Amezinium metilsulfate is a sympathomimetic drug used for the treatment of low blood pressure. Cardiovascular effects of the new sympathomimetic Amezinium metilsulphate are investigated in 25 patients compared with a control group (n = 25). During spinal/epidural anaesthesia 5 mg amezinium is given i.v. if blood pressure dropped greater than 20 mmHg. from starting-point. A significant recovery of blood pressure (epidural anaesthesia: syst 21\%, diast 9\%; spinal anaesthesia: syst 13\%, diast 6.6\%) and a decrease in heart rate (6.8\% resp. 4,5\%) are thought due to peripheral vasoconstriction. Amezinium proves a stimulating drug for alpha- and beta 1-receptors by stabilising the systemic blood pressure in spinal/epidural anaesthesia.

2-N-BOC-2-AMINOMETHYL-3-(4-CHLORO-PHENYL)-PROPIONIC ACID

C15H20ClNO4 (313.10807900000003)

benzyl 4-(methanesulfonyloxy)piperidine-1-carboxylate

C14H19NO5S (313.09838840000003)

ethyl 5-bromo-2-morpholin-4-ylbenzoate

C13H16BrNO3 (313.0313486)

ethyl 3-bromo-4-morpholin-4-ylbenzoate

C13H16BrNO3 (313.0313486)

N-Hexylpyridinium Trifluoromethanesulfonate

C12H18F3NO3S (313.0959434)

3-[1-[(3,5-difluorophenyl)methyl]indol-3-yl]prop-2-enoic acid

C18H13F2NO2 (313.09143020000005)

METHYL 4-(PROPYLSULFONYL)-3-(1H-PYRROL-1-YL)THIOPHENE-2-CARBOXYLATE

C13H15NO4S2 (313.044247)

(1-HYDROXYOCTANE-1,1-DIYL)DIPHOSPHONIC ACID

C8H20NaO7P2+ (313.058193)

methyl 4-(isopropylsulfonyl)-3-(1H-pyrrol-1-yl)thiophene-2-carboxylate

C13H15NO4S2 (313.044247)

3-(4-fluorophenyl)-5-p-tolyl-4,5-dihydro-1h-pyrazole-1-carbothioamide

C17H16FN3S (313.1048908)

N-Boc-4-(2-Bromo-acetyl)-aniline

C13H16BrNO3 (313.0313486)

Boc-(R)-3-amino-4-(2-chlorophenyl)-butyric acid

C15H20ClNO4 (313.10807900000003)

dnp-dl-glutamic acid

C11H11N3O8 (313.0546126)

Etaconazole

C13H13Cl2N3O2 (313.0384778)

N-Boc-7-Bromo-3,4-dihydro-2H-benzo[1,4]oxazine

C13H16BrNO3 (313.0313486)

2-Methyl-5-{3-[4-(methylsulfonyl)phenyl]-2-furyl}pyridine

C17H15NO3S (313.07726)

2-chloro-N-(2-fluoro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)acetamide

C14H18BClFNO3 (313.105223)

2,4-dimethoxy-4-nitrochalcone

C17H15NO5 (313.095018)

2,4-dimethoxy-2-nitrochalcone

C17H15NO5 (313.095018)

2,6-BIS(BENZO[D]OXAZOL-2-YL)PYRIDINE

C19H11N3O2 (313.0851226)

Methyl 4,5-Di(1-imidazolyl)-2-nitrobenzoate

C14H11N5O4 (313.0811006)

8-chloro-1-methyl-1,2,3,4-tetrahydropyrimido[1,6-a]pyrimidin-6-one trifluoroacetate

C10H11ClF3N3O3 (313.0441002)

Ethyl 6,7-difluoro-2-ethylmercapto-4-hydroxyquinoline-3-carboxylate

C14H13F2NO3S (313.0584172)

1-[3-(3-Bromophenoxy)propyl]-4-piperidinol

C14H20BrNO2 (313.06773200000003)

6-Fluoro-3-indolyl-b-D-galactopyranoside

C14H16FNO6 (313.0961608)

7-Amino-3-(1,2,3-triazol-4-ylthio)methyl cephalosporanic acid

C10H11N5O3S2 (313.0303296)

5-（4-Chlorophenyl)-3-p-tolyl-4,5-dihydro-1H-pyrazole-1-carboxamide

C17H16ClN3O (313.09818359999997)

2-(1-OXOPROPYL)-1-(PHENYLSULFONYL)-1H-INDOLE

C17H15NO3S (313.07726)

2,6-tns

C17H15NO3S (313.07726)

4-[4-(4-nitrophenoxy)phenyl]thiazol-2-ylamine

C15H11N3O3S (313.0521096)

(6-BROMO-HEXYL)-CARBAMIC ACID BENZYL ESTER

C14H20BrNO2 (313.06773200000003)

beta-d-glucopyranosylphenyl isothiocyanate

C13H15NO6S (313.062005)

8-Azabicyclo(3.2.1]octane, 3-(3,4-dichlorophenyl)-2-(methoxymethyl)-8-methyl-, (1R,2R,3S,5S)-

C16H21Cl2NO (313.1000116)

2,3-diphenyl-1H-indole-7-carboxylic acid

C21H15NO2 (313.110273)

3-Tropanyl-3,5-dichlorobenzoate

C15H17Cl2NO2 (313.06362820000004)

D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists

4-Thiazolidinecarboxylic acid, 2-(2-hydroxyphenyl)-3-(3-mercapto-1-oxopropyl)-

C13H15NO4S2 (313.044247)

D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D000806 - Angiotensin-Converting Enzyme Inhibitors D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents

Pipethiadene

C18H19NS2 (313.0958854)

N-(5-Chlorosalicyloyl)-8-aminocaprylic acid

C15H20ClNO4 (313.10807900000003)

4-HydroxyDuloxetine-d6

C18H19NO2S (313.1136434)

Methylthioadenosine sulfoxide

C11H15N5O4S (313.08447100000006)

4-[2-(4-Methoxycarbonylphenyl)iminohydrazinyl]benzoic acid methyl ester

C16H15N3O4 (313.106251)

N-(1,3-benzodioxol-5-ylmethyl)-6-chloroquinazolin-4-amine

C16H12ClN3O2 (313.0618002)

1-(3,4-Dimethylphenyl)-3-(2-pyrimidinylthio)pyrrolidine-2,5-dione

C16H15N3O2S (313.088493)

N-(2,3-dimethylphenyl)-5-(2-fluorophenyl)-6H-1,3,4-thiadiazin-2-amine

C17H16FN3S (313.1048908)

4-Chloro-2-[[(1-methyl-5-phenyl-2-imidazolyl)amino]methyl]phenol

C17H16ClN3O (313.09818359999997)

3-[5-(4-Fluorophenyl)-1-(2-furanylmethyl)-2-pyrrolyl]propanoic acid

C18H16FNO3 (313.11141580000003)

(R)-Hexaconazole

C14H17Cl2N3O (313.07486120000004)

(S)-Hexaconazole

C14H17Cl2N3O (313.07486120000004)

N,N,1-triethyl-2-sulfanyl-1H-1,3-benzodiazole-5-sulfonamide

C13H19N3O2S2 (313.0918634)

4-(2-Chlorophenoxy)-5-methoxy-2-(2-pyridinyl)pyrimidine

C16H12ClN3O2 (313.0618002)

2-[Bis(5-methylfuran-2-yl)methyl]-6-nitrophenol

C17H15NO5 (313.095018)

Flunitrazepam-d3

C16H12FN3O3 (313.0862654)

2-Methylthioadenosine

C11H15N5O4S (313.08447100000006)

3-(4-chlorophenyl)-2-methyl-5,6,7,8-tetrahydropyrazolo[5,1-b]quinazolin-9(4H)-one

C17H16ClN3O (313.09818359999997)

Marizomib

C15H20ClNO4 (313.10807900000003)

C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C2160 - Proteasome Inhibitor C471 - Enzyme Inhibitor

4-[4-(4-Methyl-2-methylamino-thiazol-5-YL)-pyrimidin-2-ylamino]-phenol

C15H15N5OS (313.09972600000003)

(2s,3s)-3-Formyl-2-({[(4-methylphenyl)sulfonyl]amino}methyl)pentanoic acid

C14H19NO5S (313.09838840000003)

Pteric acid

C14H13N6O3+ (313.1049088)

6-(Hydroxyethyldithio)-8-(aminomethylthio)octanoic acid

C11H23NO3S3 (313.0840008)

9-(2-hydroxy-2-oxo-4a,6,7,7a-tetrahydro-4H-furo[3,2-d][1,3,2]dioxaphosphinin-6-yl)purin-6-amine

C10H12N5O5P (313.0576032)

6-(2-carbamoylphenoxy)-3,4,5-trihydroxyoxane-2-carboxylic acid

C13H15NO8 (313.079763)

3-(4-Morpholin-4-ylthieno[3,2-d]pyrimidin-2-yl)phenol

C16H15N3O2S (313.088493)

Avenanthramide 1f

2-{[(2E)-1-hydroxy-3-(4-hydroxy-3-methoxyphenyl)prop-2-en-1-ylidene]amino}benzoate

C17H15NO5 (313.095018)

Avenanthramide 1f is a polyphenol compound found in foods of plant origin (PMID: 20428313)

7,8-Dihydropteroate

C14H13N6O3- (313.1049088)

A pteroate that is the conjugate base of 7,8-dihydropteroic acid, arising from deprotonation of the carboxy group.

Flavokermesate

C16H9O7- (313.0348264)

N-methylanthraniloyl-beta-D-glucose

C14H19NO7 (313.1161464)

S-(4-nitrobenzyl)-L-cysteinylglycine

C12H15N3O5S (313.073238)

Dihydroisopteroate

C14H13N6O3- (313.1049088)

3,5-Dihydroxy-2-(4-hydroxy-3-methoxyphenyl)-7-methoxychromenium

C17H13O6- (313.0712098)

2-[[(2R)-2-amino-3-[(4-nitrophenyl)methylsulfanyl]propanoyl]amino]acetic acid

C12H15N3O5S (313.073238)

Phosphoribosylformylglycineamidine

C8H16N3O8P (313.0674986)

2-formamido-N(1)-(5-phospho-D-ribosyl)acetamidine

C8H16N3O8P (313.0674986)

N-[[[(2-methylphenyl)-oxomethyl]hydrazo]-sulfanylidenemethyl]benzamide

C16H15N3O2S (313.088493)

6-[[[5-(Ethylthio)-1,3,4-thiadiazol-2-yl]amino]-oxomethyl]-1-cyclohex-3-enecarboxylic acid

C12H15N3O3S2 (313.05548)

Ethyl 6-(4-methoxyphenoxy)imidazo[1,2-b]pyridazine-2-carboxylate

C16H15N3O4 (313.106251)

3-[(2-Fluorophenyl)methyl]-5-methyl-4-thieno[3,4]pyrrolo[1,3-d]pyrimidinone

C16H12FN3OS (313.06850740000004)

Dantrolene(1-)

C14H9N4O5- (313.0572924)

2-[[2,3-Dihydro-1,4-benzodioxin-6-yl(oxo)methyl]amino]benzoic acid methyl ester

C17H15NO5 (313.095018)

2-[(4-Methylphenyl)sulfonylamino]acetic acid (2-oxo-3-oxolanyl) ester

C13H15NO6S (313.062005)

n-Acetylglucosamine phosphate

C8H12NO10P (313.01988220000004)

2-Nitrobenzoic acid [1-(4-methylphenyl)-1-oxopropan-2-yl] ester

C17H15NO5 (313.095018)

2-methyl-N-[(5-nitro-2-furanyl)methylideneamino]-3-imidazo[1,2-a]pyridinecarboxamide

C14H11N5O4 (313.0811006)

2-(2,4-dichloro-6-methylphenoxy)-N-(2-furylmethyl)acetamide

C14H13Cl2NO3 (313.02724480000006)

4-chloro-N-(4-hydrazinyl-6-methyl-2-pyrimidinyl)benzenesulfonamide

C11H12ClN5O2S (313.0400202)

N-[1-[(4-chlorophenyl)methyl]-4-pyrazolyl]-2-pyrazinecarboxamide

C15H12ClN5O (313.0730332)

N-(2,3-dihydro-1H-inden-5-yl)-2-[(2-nitro-3-pyridinyl)oxy]acetamide

C16H15N3O4 (313.106251)

4-Mercapto-6-oxo-3-phenyl-2-thiophen-2-yl-1,2-dihydropyrimidine-5-carbonitrile

C15H11N3OS2 (313.0343516)

1-(4-Methylphenyl)sulfonyl-4-phenyl-3-pyrazolamine

C16H15N3O2S (313.088493)

N-(2-pyridinyl)-2-[[5-(3-pyridinyl)-1,3,4-oxadiazol-2-yl]thio]acetamide

C14H11N5O2S (313.0633426)

3-[(4-Fluorophenyl)methyl]-5-methyl-4-thieno[3,4]pyrrolo[1,3-d]pyrimidinone

C16H12FN3OS (313.06850740000004)

(2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(2-hydroxybenzoyl)oxyoxane-2-carboxylate

C13H13O9- (313.0559548)

N-(2,6-Dimethyl-phenyl)-2-(9H-purin-6-ylsulfanyl)-acetamide

C15H15N5OS (313.09972600000003)

3,4-O-dimethylkaempferol

C17H13O6- (313.0712098)

7-Chloro-2,3-dihydro-2,2-dihydroxy-5-phenyl-1H-1,4-benzodiazepine-3-carboxylate

C16H10ClN2O3- (313.03799200000003)

4-[(4-Methylphenyl)thio]-3-nitro-1-benzopyran-2-one

C16H11NO4S (313.04087660000005)

2-[(4-Aminophenylsulfonyl)amino]thiazole-5-acetic acid

C11H11N3O4S2 (313.0190966)

N-[3-carbamoyl-5-[diethylamino(oxo)methyl]-4-methyl-2-thiophenyl]carbamic acid methyl ester

C13H19N3O4S (313.10962140000004)

N-(4-aminobutyl)-5-chloronaphthalene-2-sulfonamide(1+)

C14H18ClN2O2S+ (313.0777458)

3-[(6-Chloro-2-phenyl-1-benzopyran-4-ylidene)amino]-1-propanol

C18H16ClNO2 (313.0869506)

7,4-O-dimethylkaempferol

C17H13O6- (313.0712098)

[(2S)-2-[(2R)-2-[[(2R)-2-azaniumylpropanoyl]amino]propanoyl]oxy-3-hydroxypropyl] phosphate

C9H18N2O8P- (313.08007380000004)

(2S,3S,4S,5R,6S)-6-(2-carboxyphenoxy)-3,4,5-trihydroxyoxane-2-carboxylate

C13H13O9- (313.0559548)

(R)-(beta-D-Glucopyranosyloxy)phenylacetamide

C14H19NO7 (313.1161464)

Lnape 2:0/N-3:0

C10H20NO8P (313.09264900000005)

Lnape 3:0/N-2:0

C10H20NO8P (313.09264900000005)

[1-Acetyloxy-3-[2-aminoethoxy(hydroxy)phosphoryl]oxypropan-2-yl] propanoate

C10H20NO8P (313.09264900000005)

Triazophos

C12H16N3O3PS (313.06499560000003)

C471 - Enzyme Inhibitor > C47792 - Acetylcholinesterase Inhibitor

Isazofos

C9H17ClN3O3PS (313.04167320000005)

C471 - Enzyme Inhibitor > C47792 - Acetylcholinesterase Inhibitor

D-Glucose, 2-((((2-chloroethyl)nitrosoamino)carbonyl)amino)-2-deoxy-

C9H16ClN3O7 (313.06767360000003)

C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent D009676 - Noxae > D002273 - Carcinogens D000970 - Antineoplastic Agents

(S)-5-Deoxy-5-(methylsulfinyl)adenosine

C11H15N5O4S (313.08447100000006)

5-Deoxy-5-(methylsulfinyl)adenosine

C11H15N5O4S (313.08447100000006)

A member of the class of adenosines obtained by replacement of the 5-hydroxy group of adenosine by a methylsulfinyl group.

Phosphatidyl-L-serine

C8H12NO10P (313.01988220000004)

A class of aminophospholipids in which a phosphatidyl group is esterified to the hydroxy group of serine.

laccaic acid D(1-)

C16H9O7 (313.0348264)

A monocarboxylic acid that is the conjugate base of laccaic acid D, obtained from the deprotonation of the carboxy group. Major species at pH 7.3.

LPE 5:1;O

C10H20NO8P (313.09264900000005)

AT13148

C17H16ClN3O (313.09818359999997)

AT13148 is an orally active and ATP-competitive, multi-AGC kinase inhibitor with IC50s of 38 nM/402 nM/50 nM, 8 nM, 3 nM, and 6 nM/4 nM for Akt1/2/3, p70S6K, PKA, and ROCKI/II, respectively.

KRA-533

C13H16BrNO3 (313.0313486)

KRA-533 is a potent KRAS agonist. KRA-533 binds to the GTP/GDP binding pocket in the KRAS protein to prevent GTP cleavage, resulting in the accumulation of constitutively active GTP-bound KRAS that triggers both apoptotic and autophagic cell death pathways in cancer cells.

PNB-001

C18H16ClNO2 (313.0869506)

PNB-001 is an orally active CCK2 selective ligand and antagonist. PNB-001 has anti-inflammatory and analgesic activities[1].